| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3435403 | American Journal of Obstetrics and Gynecology | 2010 | 9 Pages |
Abstract
Aberrant methylation of apoptotic signaling genes results in acquired resistance to therapy. Detection of methylation in apoptotic signaling genes is potentially useful as a molecular predictive marker for strategic planning of treatment efficacy and evaluation of therapeutic outcome in CXCA, leading to an improvement of patients' survival.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Patimaporn MSc, Patcharee PhD, Pissamai MD, Temduang PhD,